Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c, Offers FY15 Guidance

Scotts Miracle-Gro (NYSE: SMG) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $454.3 million versus the consensus estimate of $438.2 million.

Scotts Miracle-Gro sees FY2015 EPS of $3.40-$3.60, versus the consensus of $3.54.The Company expects company-wide net sales to increase by approximately 4 to 5 percent in fiscal 2015

For earnings history and earnings-related data on Scotts Miracle-Gro (SMG) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• B.Riley Assumes Anika Therapeutics (ANIK) at Buy
• Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade